Kymera Therapeutics reported a net margin of -94.17% for the quarter ended Jun 2026. These financial ratios cover 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||
| EBT Margin | -141.16% | -222.88% | -384.27% | -354.79% | -470.30% | -239.72% | -479.41% | -263.01% | -1,217.22% | -40.44% | -562.85% | -198.78% | -1,929.54% | -1,092.97% | -337.10% | -737.76% | -3,350.90% | -3,414.15% | -245.06% | -116.44% | ||||||||
| EBIT Margin | -140.82% | -222.55% | -383.84% | -354.44% | -469.92% | -239.36% | -478.83% | -262.72% | -1,216.35% | -40.33% | -562.18% | -198.54% | -1,927.93% | -1,092.17% | -336.77% | -736.82% | -3,347.36% | -3,411.01% | -244.88% | -116.32% | ||||||||
| EBITDA Margin | -140.82% | -222.55% | -383.84% | -354.44% | -469.92% | -239.36% | -478.83% | -262.72% | -1,216.35% | -40.33% | -562.18% | -198.54% | -1,927.93% | -1,092.17% | -336.77% | -736.82% | -3,347.36% | -3,411.01% | -244.88% | -116.32% | ||||||||
| Operating Margin | -140.82% | -222.55% | -383.84% | -354.44% | -469.92% | -239.36% | -478.83% | -262.72% | -1,216.35% | -40.33% | -562.18% | -198.54% | -1,927.93% | -1,092.17% | -336.77% | -736.82% | -3,347.36% | -3,411.01% | -244.88% | -116.32% | ||||||||
| Net Margin | -141.16% | -222.88% | -384.27% | -349.64% | -450.24% | -216.03% | -432.37% | -234.96% | -1,118.17% | -30.01% | -472.02% | -163.98% | -1,670.33% | -956.88% | -296.75% | -667.60% | -2,973.05% | -3,030.70% | -201.47% | -94.17% | ||||||||
| FCF Margin | -184.73% | -256.94% | -423.79% | -344.97% | -371.85% | -247.28% | -506.83% | -278.71% | -840.21% | -7.48% | -456.82% | -185.67% | -1,336.57% | -848.26% | -360.26% | -541.50% | -930.82% | -2,528.50% | -259.78% | -79.85% | ||||||||
| Efficiency | ||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 538.42M | 624.18M | 584.48M | 543.24M | 580.95M | 620.80M | 608.52M | 597.92M | 567.16M | 564.07M | 722.00M | 847.14M | 930.43M | 1,006.44M | 948.17M | 1,024.69M | 1,116.56M | 1,422.43M | 1,705.91M | 1,657.23M | ||||||||
| Asset Utilization RatioAsset Util. | 0.13 | 0.12 | 0.11 | 0.10 | 0.08 | 0.08 | 0.08 | 0.09 | 0.08 | 0.14 | 0.11 | 0.10 | 0.09 | 0.05 | 0.06 | 0.04 | 0.04 | 0.03 | 0.03 | 0.06 | ||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -409.10 | -666.55 | -900.80 | -995.37 | -0.00M | -654.75 | -824.11 | -903.81 | -0.00M | -371.38 | -838.13 | -834.84 | -0.00M | -0.00M | -0.00M | -782.94 | -944.09 | -0.00M | -0.00M | -933.42 | ||||||||
| Times Interest Earned | -409.10 | -666.55 | -900.80 | -995.37 | -0.00M | -654.75 | -824.11 | -903.81 | -0.00M | -371.38 | -838.13 | -834.84 | -0.00M | -0.00M | -0.00M | -782.94 | -944.09 | -0.00M | -0.00M | -933.42 | ||||||||
| Valuation | ||||||||||||||||||||||||||||
| Price to EarningsP/E | -104.88 | -96.11 | -59.17 | -25.36 | -27.72 | -39.40 | -40.02 | -32.82 | -14.58 | -98.50 | -50.79 | -43.70 | -49.04 | -36.90 | -27.17 | -40.19 | -49.41 | -72.75 | -98.87 | -155.09 | ||||||||
| Price to SalesP/S | 148.05 | 214.21 | 227.36 | 88.66 | 124.80 | 85.12 | 173.02 | 77.12 | 163.02 | 29.55 | 239.76 | 71.65 | 819.17 | 353.06 | 80.64 | 268.31 | 0.00M | 0.00M | 199.18 | 146.05 | ||||||||
| Price to BookP/B | 6.23 | 7.12 | 5.10 | 2.57 | 2.32 | 2.80 | 3.55 | 2.92 | 1.95 | 3.58 | 3.47 | 2.68 | 3.43 | 3.12 | 2.27 | 3.17 | 4.29 | 4.01 | 4.45 | 6.29 | ||||||||
| Enterprise Value | 2,474.42M | 2,829.61M | 1,766.82M | 628.56M | 710.03M | 966.62M | 1,240.96M | 905.85M | 412.93M | 1,040.32M | 1,945.85M | 1,327.98M | 2,514.56M | 2,121.79M | 1,318.99M | 2,413.68M | 3,554.87M | 5,479.51M | 6,194.02M | 8,802.34M | ||||||||
| EV to EBIT | -86.41 | -83.24 | -47.84 | -15.40 | -15.82 | -25.02 | -27.38 | -20.88 | -7.18 | -53.87 | -33.65 | -26.08 | -34.86 | -26.27 | -17.72 | -28.55 | -38.42 | -55.97 | -73.60 | -116.42 | ||||||||
| EV to EBITDA | -86.41 | -83.24 | -47.84 | -15.40 | -15.82 | -25.02 | -27.38 | -20.88 | -7.18 | -53.87 | -33.65 | -26.08 | -34.86 | -26.27 | -17.72 | -28.55 | -38.42 | -55.97 | -73.60 | -116.42 | ||||||||
| Market Capitalization | 3,010.81M | 3,272.03M | 2,187.63M | 1,020.87M | 1,191.94M | 1,373.78M | 1,637.83M | 1,273.42M | 770.76M | 1,415.20M | 2,466.40M | 1,837.94M | 3,064.53M | 2,610.53M | 1,782.14M | 3,079.13M | 4,060.55M | 6,327.78M | 6,844.95M | 9,493.33M | ||||||||
| Price to FCFP/FCF | -80.15 | -83.37 | -53.65 | -25.70 | -33.56 | -34.42 | -34.14 | -27.67 | -19.40 | -395.31 | -52.48 | -38.59 | -61.29 | -41.62 | -22.38 | -49.55 | -157.83 | -87.20 | -76.67 | -182.91 | ||||||||
| EV to FCF | -65.87 | -72.10 | -43.33 | -15.82 | -19.99 | -24.22 | -25.87 | -19.68 | -10.39 | -290.59 | -41.41 | -27.88 | -50.29 | -33.83 | -16.57 | -38.84 | -138.17 | -75.51 | -69.38 | -169.60 | ||||||||
| EV to CFO | -66.41 | -73.78 | -43.85 | -16.12 | -20.72 | -24.45 | -28.22 | -25.69 | -13.05 | 129.31 | -49.15 | -30.93 | -50.10 | -34.34 | -16.66 | -40.31 | -131.13 | -82.09 | -69.72 | -162.81 | ||||||||
| Return Ratios | ||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -140.82% | -222.55% | -383.84% | -354.44% | -469.92% | -239.36% | -478.83% | -262.72% | -1,216.35% | -40.33% | -562.18% | -198.54% | -1,927.93% | -1,092.17% | -336.77% | -736.82% | -3,347.36% | -3,411.01% | -244.88% | -116.32% | ||||||||
| Return on Capital Employed [ROCE]ROCE | -17.87% | -18.91% | -25.05% | -30.80% | -31.97% | -29.35% | -31.04% | -31.70% | -36.68% | -34.60% | -26.74% | -23.64% | -23.17% | -27.87% | -31.29% | -33.28% | -31.80% | -26.09% | -21.85% | -22.08% | ||||||||
| Return on Assets [ROA]ROA | -14.76% | -16.13% | -21.30% | -25.88% | -26.99% | -26.00% | -27.91% | -28.84% | -32.63% | -29.38% | -24.69% | -21.93% | -21.54% | -26.02% | -29.37% | -30.46% | -29.79% | -24.59% | -21.07% | -21.15% |